(Q46650071)

23 December 2017

title

Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity (English)

1 reference

23 December 2017

cerebral amyloid angiopathy

1 reference

1 reference

8

1 reference

23 December 2017

Gregory J Zipfel

12

object named as

Gregory J Zipfel

1 reference

23 December 2017

Kelly R Bales

1

1 reference

23 December 2017

Sharon M O'Neill

2

1 reference

23 December 2017

Nikolay Pozdnyakov

3

1 reference

23 December 2017

Feng Pan

4

1 reference

23 December 2017

David Caouette

5

1 reference

23 December 2017

YeQing Pi

6

1 reference

23 December 2017

Kathleen M Wood

7

1 reference

23 December 2017

John R Cirrito

9

1 reference

23 December 2017

Byung-Hee Han

10

1 reference

23 December 2017

Andrew W Johnson

11

1 reference

23 December 2017

Tarek A Samad

13

1 reference

23 December 2017

language of work or name

English

0 references

publication date

22 October 2015

1 reference

23 December 2017

published in

Brain

1 reference

23 December 2017

volume

139

1 reference

23 December 2017

issue

Pt 2

1 reference

23 December 2017

page(s)

563-577

1 reference

23 December 2017

Cerebral amyloid angiopathy pathology and cognitive domains in older persons

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

CSF markers for incipient Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Vessel ultrastructure in APP23 transgenic mice after passive anti-Abeta immunotherapy and subsequent intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Chronic administration of an aglycosylated murine antibody of ponezumab does not worsen microhemorrhages in aged Tg2576 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Cerebrovascular lesions induce transient β-amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

The pathobiology of vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Alzheimer disease and cerebrovascular pathology: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Abeta quantification following passive immunization with Abeta antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Hereditary cerebral hemorrhage with amyloidosis-Dutch type

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Clinical phenotypes of Cerebral Amyloid Angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Diffusion of molecules in brain extracellular space: theory and experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Two-photon imaging of dendritic spine development in the mouse cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Cerebral hemorrhage after passive anti-Abeta immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Impaired visual evoked flow velocity response in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

The A4 study: stopping AD before symptoms begin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Cerebral amyloid angiopathy: Pathogenesis and effects on the ageing and Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

Thinned-skull cranial window technique for long-term imaging of the cortex in live mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV313

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWV313

1 reference

23 December 2017

PubMed ID

26493635

1 reference

23 December 2017